The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> MEDICINE >> NEWS
Study recommends treatment change for pre-leukemia disease

A new study finds that longer courses of a mild form of chemotherapy may help patients with a bone marrow disease only recently considered a form of cancer. Writing in the April 15, 2006 issue of CANCER (http://www.interscience.wiley.com/cancer-newsroom), a peer-reviewed journal of the American Cancer Society, researchers say the study found that 45 percent of patients with Myelodysplastic Syndrome (MDS) who relapse did respond to a second course of treatment, but that the quality and duration of the second response was inferior to the initial treatment, leading researchers to believe that longer initial treatments may be more beneficial to patient outcome.

MDS is a bone marrow disease that causes an increasing number of dysfunctional blood cells called blasts to develop from stem cells and proliferate in the blood stream at the expense of normal cells. As a result, fewer normal red blood cells will circulate to carry oxygen to cells resulting in anemia; fewer white blood cells will be available to fight infections; and fewer platelets to control bleeding. Although MDS has not been considered cancer in the past, most hematologists (specialists in diseases of the blood) now think it is a form of bone marrow cancer (i.e. leukemia).

MDS generally afflicts adults over 50 years old, and therapy is supportive rather than curative. However, a subset of MDS patients will develop blood cell cancer, or leukemia. These high-risk patients have been shown to benefit from a new DNA hypomethylating agent, decitabine, undergoing clinical trials. The results of these trials are revealed in a related article by Kantarjian et al. also published in the April 15, 2006 issue of CANCER.

Little is known about the optimal duration of treatment with decitabine and the effect of retreatment for relapse. Led by Michael Lbbert, M.D., Ph.D. of the University of Freiburg Medical Center in Freiburg, German
'"/>

Contact: David Greenberg
dgreenbe@wiley.com
201-748-6484
John Wiley & Sons, Inc.
13-Mar-2006


Page: 1 2

Related medicine news :

1. Study, meta-analysis examine factors associated with death from heatstroke
2. Study says COPD testing is not measuring up
3. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
4. Study reveals gaps in vaccine financing for underinsured children
5. Study suggests nonpharmaceutical interventions may be helpful in severe influenza outbreaks
6. Study shows radiofrequency ablation highly effective in treating kidney tumors
7. Study says normal but out-of-control enzyme may be culprit that signals some cells to become cancer
8. Study finds HIV protease inhibitor drugs may adversely affect the scaffolding of the cell nucleus
9. Study outlines how stroke, head injury can increase risk of Alzheimers disease
10. Study identifies new regulator of fat metabolism
11. Study shows Diachrome improves blood sugar control in people with type 2 diabetes

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Study recommends treatment change for pre leukemia disease

(Date:11/25/2009)...TORONTOandCALGARY,Nov.25/PRNewswire/-SentinelleMed...aging(MRI)coilsandsoftwareandCalgaryScientificInc....veintroducedawebversionofAegis(TM)Breast4DAdvanced...ceisthefirsttrulyzero-footprintWebclientbasedmedic...reWeb(TM)platformallowsforzero-footprintaccess-req...
(Date:11/25/2009)...SANFRANCISCO,Nov.25/PRNewswire/--TheBayAreaAirQual...ter Spare the Air Alert forThursday,...relogsoranyothersolidfuel,bothindoorsandoutdoors. ...irqualitytomorrow,"saidJackBroadbent,executiveoffi...respectthehealthoftheirneighborsandfellowcommunity...
(Date:11/25/2009)...tress increase blood pressure? This simple questi... years. New Stress-related gene Modulates High Bl...blood pressure? This simple question has been the...w research has for the first time established a li...pressure response to stress in mice as well as hum...
(Date:11/25/2009)...s often plagued by neurological symptoms, study fi...ews) -- Neurological side effects are among the po...esticular cancer who were treated with cisplatin-b... study included 1,409 Norwegian men treated for un...ho took part in a follow-up survey conducted from ...
(Date:11/25/2009)...DGE, Mass. -- A cancer vaccine carried into the bo...lant is the first to successfully eliminate tumors...urnal Science Translational Medicine . , The ne...gists at Harvard University, uses plastic disks im...ed under the skin to reprogram the mammalian immun...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:New stress-related gene modulates high blood pressure in mice and men 2Health News:Implant-based cancer vaccine is first to eliminate tumors in mice 2
(Date:11/25/2009)...EWYORK,Nov.25/PRNewswire/--Reportlinker.comannounc...logue: ,, IntranasalDrugDelivery-USMarketTrend...67/Intranasal-Drug-Delivery---US-Market-Trends--An...etiswitnessinganexpansionoftherapeuticapplications...tothedeliveryofsystemictherapeuticdrugs.Thefutureo...
(Date:11/25/2009)...OUNTAINVIEW,Calif.,Nov.25/PRNewswire/-- ChemoCent...fromtheCompany,sPROTECT-1(theProspectiveRandomized...cet-EN(TM)(CCX282-B)inpatientswithmoderate-to-seve...avorablesafetyandtolerabilityprofile.Thestudydemon...iseaseseverityasdefinedasa70-pointdecreaseintheCro...
(Date:11/24/2009)...RVINE,Calif.,Nov.24/PRNewswire-FirstCall/--Endolog...etreatmentsforaorticdisorders,announcedtodaythatit...n,thepatentinfringementlawsuitbroughtagainstitinOc...atesDistrictCourtinIndianapolis,Indiana. ,, End...eUnitedStatesPatentandTrademarkOffice(USPTO)conduc...
Breaking Medicine Technology:Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues 3B Improved Bottom Line 14741 1ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues 3B Improved Bottom Line 14741 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues 3B Improved Bottom Line 14741 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues 3B Improved Bottom Line 14741 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues 3B Improved Bottom Line 14741 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues 3B Improved Bottom Line 14741 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues 3B Improved Bottom Line 14741 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues 3B Improved Bottom Line 14741 8ARKRAY Inc Receives FDA Clearance for New GLUCOCARD 28R 29 Vital 28TM 29 Blood Glucose Monitoring System 6035 1ARKRAY Inc Receives FDA Clearance for New GLUCOCARD 28R 29 Vital 28TM 29 Blood Glucose Monitoring System 6035 2ResMed Inc Announces Record Financial Results for the Quarter Ended September 30 2009 6030 1ResMed Inc Announces Record Financial Results for the Quarter Ended September 30 2009 6030 2ResMed Inc Announces Record Financial Results for the Quarter Ended September 30 2009 6030 3ResMed Inc Announces Record Financial Results for the Quarter Ended September 30 2009 6030 4ResMed Inc Announces Record Financial Results for the Quarter Ended September 30 2009 6030 5ResMed Inc Announces Record Financial Results for the Quarter Ended September 30 2009 6030 6ResMed Inc Announces Record Financial Results for the Quarter Ended September 30 2009 6030 7
Other News:
...region of the human brain that scientists believe ...singly functions much like a digital computer, acc... the University of Colorado at Boulder.... The fin...functioning of human intelligence. ... In a review...
...ldwide, women, unlike men, are at most risk of vio...petrators, according to an Article in this week's ...more than a quarter of women reported physical or ... their lives. In all but one setting women were at...
(Philadelphia, PA) -- Researchers at the University of Pennsylvania School of Medicine have discovered the major disease protein for two neurodegenerative disorders: a type of frontotemporal dementia
...egalised and regulated system for paying people to...e large demand for transplants and prevent exploit...'s BMJ.... The author an organ transplant surgeon...s to be made for live organ donation, saying it do...
health news:Human brain region functions like digital computer, says CU-Boulder professor 2health news:Women worldwide more at risk of violence from an intimate partner than from other people 2health news:Penn researchers find Lou Gehrig's, FTD disease protein 2health news:Penn researchers find Lou Gehrig's, FTD disease protein 3
...amin supplements help critically ill patients reco...Harborview surgeons and dietitians is.evaluating t...n in intensive.care unit (ICU) patients at Harborv...acute respiratory distress syndrome.(ARDS), an unc...
... The threat of imminent death awaits the 250,000 p...pital each year, especially those for whom.defibri...ating.. A clinical trial performed by Unive...ept. 16 issue of the New England Journal of Medici...
... CHAPEL HILL - In 1996, U.S. consumers spent more ...edients extracted from foods, herbs and plants tha..... By last year, the market had almost doub... more than $14 billion in the year 2000. Unlike dr...
...rials with built-in receptors that can interact wi...d as scaffolding to help construct new cartilage a...t the British Association's.Festival of Science in...g.developed by Dr France and colleagues at the Uni...
health news:Study tests vitamins in recovery from trauma 2health news:Drug offers new hope for victims of cardiac arrest 2health news:UNC-CH nutrition expert says nation should regulate some diet supplements 2health news:UNC-CH nutrition expert says nation should regulate some diet supplements 3